← Evidence map

ArticleAmerican journal of hematology2026

Mitigating HLA Disparity in AML Transplantation: Comparable Outcomes After Haploidentical and 9/10 Mismatched Unrelated Donor Transplantation With Treosulfan and PTCy.

Daniele Avenoso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Mitigating HLA Disparity in AML Transplantation: Comparable Outcomes After Haploidentical and 9/10 Mismatched Unrelated Donor Transplantation With Treosulfan and PTCy. | OpenQuestion